Monopar Therapeutics Inc.MNPRNASDAQ

Revenue (LTM)

Net Income (LTM)

$-16M

-85.5% YoY

Free Cash Flow

$-6M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	0	0	0
Gross Profit	0	0	0	0	0
Operating Income	-7	-9↓40.2%	-11↓15.4%	-9↑16.2%	-16↓83.0%
Net Income	-6	-9↓44.4%	-11↓15.5%	-8↑20.1%	-16↓85.5%
EBITDA	0	-9	-11↓15.4%	-9↑16.2%	-16↓83.0%
EPS Diluted	-0.58	-0.73↓25.9%	-0.83↓13.7%	-0.58↑30.1%	-1.36↓134.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	17	20↑21.3%	8↓59.7%	7↓11.2%	46↑530.6%
Total Current Assets	17	21↑22.2%	13↓35.8%	7↓44.3%	60↑722.2%
Total Assets	17	21↑21.7%	13↓35.5%	7↓44.5%	60↑720.8%
Total Current Liabilities	1	2↑34.3%	3↑98.0%	2↓43.8%	5↑199.0%
Total Liabilities	1	2↑34.3%	3↑98.5%	2↓44.0%	5↑199.0%
Total Equity	16	19↑20.7%	10↓46.7%	6↓44.6%	55↑885.0%
Total Debt	0	0	0	0	0
Net Debt	-17	-20↓21.3%	-8↑59.7%	-7↑11.1%	-46↓530.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-5	-7↓56.9%	-7↑1.2%	-8↓8.7%	-6↑18.5%
Capital Expenditure	0	0	0	0	0
Free Cash Flow	-5	-7↓56.9%	-7↑1.2%	-8↓8.7%	-6↑18.5%
Stock-Based Comp	1	1↑11.1%	2↑11.8%	2↑15.6%	1↓39.9%
Net Change in Cash	4	4↑1.2%	-12↓439.7%	-1↑92.4%	39↑4289.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance